ADMA Biologics logo
ADMA Biologics ADMA
€ 7.46 0.16%
report update icon

Quartalsbericht 2026-Q2
hinzugefügt 05.08.2026

ADMA Biologics DSO | ADMA

DSO Jährlich ADMA Biologics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
74.6 33.1 30.3 52.2 94.3 114 43.2 29.9 62.2 34.9 47 - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
114 29.9 56

DSO Vierteljährlich ADMA Biologics

2026-Q2 2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
101 109 84.1 78.2 59.4 - 30.6 33.9 42.9 - 46.1 48 33.7 - 44.2 59.9 85 - 96.9 99.5 81.3 - 118 155 74.7 - 43.8 48.3 62.9 31.3 30 27.3 59.5 - 74.9 104 85 - 31.6 40.9 41.7 - 45.5 64.4 39.7 - 25.6 23.4 11.2 - - 20 21 - 9.9 15.5 406 - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
406 9.9 64.6

DSO anderer Aktien in der Pharmaeinzelhändler

Name DSO Preis % 24h Marktkapitalisierung Land
AbbVie AbbVie
ABBV
258 $ 263.04 0.49 % $ 465 B usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
173 $ 11.41 2.15 % $ 3.41 B canadaCanada
Фармсинтез Фармсинтез
LIFE
209 - - - russiaRussia
Aclaris Therapeutics Aclaris Therapeutics
ACRS
7.42 $ 5.53 6.02 % $ 678 M usaUSA
ADC Therapeutics SA ADC Therapeutics SA
ADCT
111 $ 1.09 3.74 % $ 139 M schweizSchweiz
Clovis Oncology Clovis Oncology
CLVS
271 - -7.23 % $ 13 M usaUSA
Chimerix Chimerix
CMRX
52.5 - - $ 756 M usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
5.06 - - $ 401 M usaUSA
Eiger BioPharmaceuticals Eiger BioPharmaceuticals
EIGR
39.7 - -9.21 % $ 2.55 M usaUSA
Fusion Pharmaceuticals Fusion Pharmaceuticals
FUSN
6 - - $ 1.41 B canadaCanada
Guardion Health Sciences Guardion Health Sciences
GHSI
62.6 - -0.31 % $ 3.64 M usaUSA
Genocea Biosciences Genocea Biosciences
GNCA
24.9 - -15.0 % $ 3.04 M usaUSA
Gritstone Oncology Gritstone Oncology
GRTS
40.3 - 0.42 % $ 213 M usaUSA
G1 Therapeutics G1 Therapeutics
GTHX
52.6 - - $ 370 M usaUSA
Humanigen Humanigen
HGEN
598 - -81.12 % $ 4.28 M usaUSA
HOOKIPA Pharma HOOKIPA Pharma
HOOK
3.33 - -6.92 % $ 79.4 M usaUSA
Intercept Pharmaceuticals Intercept Pharmaceuticals
ICPT
130 - - $ 643 M usaUSA
IMV IMV
IMV
2.16 K - - $ 13.1 M canadaCanada
Intra-Cellular Therapies Intra-Cellular Therapies
ITCI
257 - - $ 13.6 B usaUSA
Chinook Therapeutics Chinook Therapeutics
KDNY
0.926 - - $ 2.6 B usaUSA
Karuna Therapeutics Karuna Therapeutics
KRTX
15.9 - - $ 12.2 B usaUSA
La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company
LJPC
34.8 - - $ 154 M usaUSA
LogicBio Therapeutics LogicBio Therapeutics
LOGC
9.88 - - $ 229 M usaUSA
Lumos Pharma Lumos Pharma
LUMO
13.6 - - $ 35.3 M usaUSA
Merrimack Pharmaceuticals Merrimack Pharmaceuticals
MACK
0.362 - - $ 216 M usaUSA
Mirati Therapeutics Mirati Therapeutics
MRTX
12.7 - - $ 3.3 B usaUSA
9 Meters Biopharma 9 Meters Biopharma
NMTR
91.7 - -42.97 % $ 1.05 M usaUSA
Nymox Pharmaceutical Corporation Nymox Pharmaceutical Corporation
NYMX
12.5 - -19.68 % $ 18.4 M canadaCanada
Oncternal Therapeutics Oncternal Therapeutics
ONCT
20.6 - -24.12 % $ 1.56 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
84.9 - - $ 109 M usaUSA
Orchard Therapeutics plc Orchard Therapeutics plc
ORTX
80.1 - 1.02 % $ 90.8 M britainBritain